Literature DB >> 1347866

Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure.

D P Moore1, A R Weston, J M Hughes, C M Oakley, J G Cleland.   

Abstract

Exercise capacity in patients with stable heart failure may be influenced by prolonged drug treatment or exercise training, but acute interventions are generally thought to have little effect. Cardiorespiratory responses to exercise were studied in 12 consecutive patients with chronic congestive heart failure who underwent serial submaximal and maximal exercise tests at inspired oxygen concentrations of 21% (room air), 30%, and 50%. Mean (SD) exercise duration during progressive testing to maximum exercise capacity was prolonged from 548 (276) s on room air to 632 (285) s on 50% oxygen (p = 0.012). During steady-state exercise at 45 W, oxygen enrichment to 50% was associated with significantly increased arterial oxygen saturation (94.6 [1.9]% to 97.5 [1.3]%), and significantly reduced minute ventilation (36.1 [8.6] l/min to 28.1 [5.9] l/min), cardiac output (7.5 [2.3] l/min to 6.5 [1.9] l/min), and subjective scores for fatigue and breathlessness (13.9 [3.1] to 11.5 [3.5]) compared with room air intermediate changes were observed with 30% inspired oxygen. Increased inspired oxygen concentrations can improve exercise performance acutely and modify the ventilatory response to exercise in patients with heart failure. Hyperoxia reduces ventilatory response and circulatory demand while maintaining oxygen delivery at a given workload. The potential benefits of increased inspired oxygen concentrations in the treatment of chronic heart failure merit further assessment.

Entities:  

Mesh:

Year:  1992        PMID: 1347866     DOI: 10.1016/0140-6736(92)90288-e

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Management of end stage cardiac failure.

Authors:  Miriam J Johnson
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

2.  Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors.

Authors:  Fabio Esposito; Odile Mathieu-Costello; Ralph Shabetai; Peter D Wagner; Russell S Richardson
Journal:  J Am Coll Cardiol       Date:  2010-05-04       Impact factor: 24.094

Review 3.  Medical treatment beyond ACE inhibition: false promise or lack of vision?

Authors:  J T Walsh; A J Cowley
Journal:  Br Heart J       Date:  1994-09

4.  A possible role for systemic hypoxia in the reactive component of pulmonary hypertension in heart failure.

Authors:  Bryan J Taylor; Cesar R Mojica; Thomas P Olson; Paul R Woods; Robert P Frantz; Bruce D Johnson
Journal:  J Card Fail       Date:  2013-01       Impact factor: 5.712

5.  The Effects of Ischemia and Hyperoxygenation on Hair Growth and Cycle.

Authors:  Harunosuke Kato; Kahori Kinoshita; Natsumi Saito; Koji Kanayama; Masanori Mori; Natsumi Asahi; Ataru Sunaga; Katsutoshi Yoshizato; Satoshi Itami; Kotaro Yoshimura
Journal:  Organogenesis       Date:  2020-07-30       Impact factor: 2.500

6.  Does lung diffusion impairment affect exercise capacity in patients with heart failure?

Authors:  P G Agostoni; M Bussotti; P Palermo; M Guazzi
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

7.  Effects of intravenous low-dose dopamine infusion on glucose regulation during prolonged aerobic exercise.

Authors:  Blair D Johnson; Ana B Peinado; Sushant M Ranadive; Timothy B Curry; Michael J Joyner
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-09-20       Impact factor: 3.619

Review 8.  Carotid body modulation in systolic heart failure from the clinical perspective.

Authors:  Piotr Niewinski
Journal:  J Physiol       Date:  2016-04-13       Impact factor: 5.182

9.  Usefulness of arterial blood gas estimations during exercise in patients with chronic heart failure.

Authors:  A L Clark; A J Coats
Journal:  Br Heart J       Date:  1994-06

Review 10.  Pathophysiology and potential clinical applications for testing of peripheral chemosensitivity in heart failure.

Authors:  Piotr Niewinski
Journal:  Curr Heart Fail Rep       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.